Nasdaq Txg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq txg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Txg Today - Breaking & Trending Today

Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00

10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […] ....

United States , Benjaminj Hindson , Serge Saxonov , Asia Pacific , Stifel Nicolaus , Harvest Fund Management Co , Canaccord Genuity Group , Genomics Inc , Powell Investment Advisors , Deutsche Bank Aktiengesellschaft , Genomics Company Profile , Associates Corp , Allspring Global Investments Holdings , Free Report , Genuity Group , Bank Aktiengesellschaft , Moderate Buy , Genomics Stock Down , Get Free Report , Global Investments Holdings , Fund Management , Genomics Company , Middle East , Genomics Daily , 10x Genomics , Nasdaq Txg ,

Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)

10x Genomics, Inc. (NASDAQ:TXG – Free Report) – William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior forecast of […] ....

United States , Asia Pacific , Serge Saxonov , Justinj Mcanear , William Blair , Genomics Inc , Goldman Sachs Group , Nikko Asset Management Americas Inc , Sumitomo Mitsui Trust Holdings Inc , Venrock Management , Genomics Company Profile , Investment Management , Free Report , Get Free Report , Genomics Stock Down , Mitsui Trust Holdings , Asset Management Americas , Genomics Company , Middle East , Genomics Daily , 10x Genomics , Nasdaq Txg , Earnings Estimates ,

Stifel Nicolaus Trims 10x Genomics (NASDAQ:TXG) Target Price to $53.00

10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by Stifel Nicolaus from $63.00 to $53.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity Group reduced their price target […] ....

United States , Stifel Nicolaus , Serge Saxonov , Justinj Mcanear , Asia Pacific , Associates Corp , Canaccord Genuity Group , Allspring Global Investments Holdings , Xponance Inc , Group Ltd , Genomics Inc , Securities Exchange Commission , Deutsche Bank Aktiengesellschaft , Free Report , Genuity Group , Moderate Buy , Genomics Stock , Get Free Report , Exchange Commission , Global Investments Holdings , Middle East , Genomics Daily , 10x Genomics , Nasdaq Txg , Lower Price Target ,

Stifel Nicolaus Trims 10x Genomics (NASDAQ:TXG) Target Price to $53.00

10x Genomics (NASDAQ:TXG – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from $63.00 to $53.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 103.85% from the […] ....

United States , Asia Pacific , Justinj Mcanear , Stifel Nicolaus , Serge Saxonov , Stifel Nicolau , Genomics Inc , Investment Management , Sumitomo Mitsui Trust Holdings Inc , Canaccord Genuity Group , Brown Capital Management , Vanguard Group Inc , Deutsche Bank Aktiengesellschaft , Get Free Report , Bank Aktiengesellschaft , Genuity Group , Genomics Stock , Mitsui Trust Holdings , Capital Management , Middle East , Genomics Daily , 10x Genomics , Nasdaq Txg , Lower Price Target ,